BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5034245)

  • 21. Tumour immunology.
    Mitchison NA
    Essays Fundam Immunol; 1973; 0(1):57-66. PubMed ID: 4547342
    [No Abstract]   [Full Text] [Related]  

  • 22. Levels of Ia-like antigen bearing lymphocytes in patients with solid primary tumors.
    Cordiali-Fei P; Natali PG; Pecci G; Pellegrino MA; Ferrone S
    J Clin Lab Immunol; 1981 Nov; 6(3):197-9. PubMed ID: 6951050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current immunologic findings in bladder cancer].
    Seyfarth M; Hudemann B; Erdmann T
    Z Urol Nephrol; 1982 Mar; 75(3):153-7. PubMed ID: 7102126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of cellular immunity in multiple sclerosis].
    Caputo D; Zibetti A; Manara F; Bisaccia G
    Minerva Med; 1977 Feb; 68(6):413-6. PubMed ID: 300150
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages.
    Petty HR; Ware BR; Remold HG; Rocklin RE
    J Immunol; 1980 Jan; 124(1):381-7. PubMed ID: 6153099
    [No Abstract]   [Full Text] [Related]  

  • 26. Preliminary characterization of a colon tumour tissue preparation used in macrophage electrophoretic mobility (MEM) test1.
    Grossmann H; Müller M; Heidl G; Irmscher J; Kotzsch M; Wagner H
    Arch Geschwulstforsch; 1981; 51(4):310-6. PubMed ID: 7032449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.
    Baldwin RW; Embleton MJ; Price MR
    Int J Cancer; 1973 Jul; 12(1):84-92. PubMed ID: 4790711
    [No Abstract]   [Full Text] [Related]  

  • 28. Macrophage electrophoretic mobility test for brain tumors and malignancies.
    Yongde S; Zhensheng T; Chuanshen L; Baoguo X; Zijun L; Yifei S; Yanfang J; Xindi Y; Meizhen L; Xuezhen S
    Chin Med J (Engl); 1979 Mar; 92(3):211-5. PubMed ID: 109261
    [No Abstract]   [Full Text] [Related]  

  • 29. [Discrimination of nonspecific effects in the macrophage-electrophoretic-mobility test using dimethyl sulfoxide].
    Wagner H; Irmscher J; Kotzsch M; Grossmann H; Müller M
    Biomed Biochim Acta; 1983; 42(1):129-37. PubMed ID: 6192810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
    Glaves D; Harlos JP; Weiss L
    Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human lymphocytes-macrophages interaction: a good prognostic sign in malignant lymphoma.
    Shohat B; Solomon F; Sidi Y; Pinkhas J
    Rev Esp Oncol; 1981; 28(3):441-7. PubMed ID: 7186669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte-antigen interaction in electrophoretic mobility test for cellular sensitization.
    Caspary EA
    Nat New Biol; 1971 May; 231(18):24. PubMed ID: 5282846
    [No Abstract]   [Full Text] [Related]  

  • 33. Density gradient electrophoresis of mouse spleen lymphocytes. Differential mobilities of macrophages, responding and stimulating cells in mixed lymphocyte culture.
    Platsoucas CD; Robbins SG; Catsimpoolas N
    Int Arch Allergy Appl Immunol; 1980; 63(3):258-65. PubMed ID: 6448230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
    Muhrer KH; Kahle M; Pasurka B
    Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
    Arvilommi H; Dale MM; Desai HN; Mongar JL; Richardson M
    Br J Cancer; 1977 Nov; 36(5):545-9. PubMed ID: 588418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immunity against malignant melanoma in monozygous twins.
    Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
    Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
    [No Abstract]   [Full Text] [Related]  

  • 37. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
    Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
    Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of macrophage electrophoretic mobility (MEM) test as an indicator of cellular immunity in ocular tumours.
    Rahi AH; Otiko G; Winder AF
    Br J Ophthalmol; 1976 Aug; 60(8):589-93. PubMed ID: 61762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunodiagnosis of malignant tumors. Test of electrophoretic mobility of macrophages].
    Strejcek J; Jíra M; Suhajová E; Písa P; Malbohan I
    Cas Lek Cesk; 1984 Apr; 123(17):511-6. PubMed ID: 6380732
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immune reactivity in colorectal cancer--clinical value from a surgical viewpoint].
    Muhrer KH; Schwemmle K; Filler D; Kahle M
    Chirurg; 1982 Feb; 53(2):112-6. PubMed ID: 7075339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.